| M1 macrophage-derived nanovesicles potentiate the anticancer efficacy of immune checkpoint inhibitors YW Choo, M Kang, HY Kim, J Han, S Kang, JR Lee, GJ Jeong, SP Kwon, ... ACS nano 12 (9), 8977-8993, 2018 | 341 | 2018 |
| T‐cell‐mimicking nanoparticles for cancer immunotherapy M Kang, J Hong, M Jung, SP Kwon, SY Song, HY Kim, JR Lee, S Kang, ... Advanced materials 32 (39), 2003368, 2020 | 92 | 2020 |
| Nanocomplex‐mediated in vivo programming to chimeric antigen receptor‐M1 macrophages for cancer therapy M Kang, SH Lee, M Kwon, J Byun, D Kim, C Kim, S Koo, SP Kwon, ... Advanced materials 33 (43), 2103258, 2021 | 89 | 2021 |
| T‐cell‐derived nanovesicles for cancer immunotherapy J Hong, M Kang, M Jung, YY Lee, Y Cho, C Kim, SY Song, CG Park, ... Advanced Materials 33 (33), 2101110, 2021 | 48 | 2021 |
| Local delivery of senolytic drug inhibits intervertebral disc degeneration and restores intervertebral disc structure S Lim, SB An, M Jung, HP Joshi, H Kumar, C Kim, SY Song, JR Lee, ... Advanced healthcare materials 11 (2), 2101483, 2022 | 43 | 2022 |
| Nanoparticle‐Mediated Blocking of Excessive Inflammation for Prevention of Heart Failure Following Myocardial Infarction SP Kwon, BH Hwang, EH Park, HY Kim, JR Lee, M Kang, SY Song, ... Small 17 (32), 2101207, 2021 | 32 | 2021 |
| Nanovesicle‐Mediated Targeted Delivery of Immune Checkpoint Blockades to Potentiate Therapeutic Efficacy and Prevent Side Effects M Jung, M Kang, BS Kim, J Hong, C Kim, CH Koh, G Choi, Y Chung, ... Advanced Materials 34 (9), 2106516, 2022 | 31 | 2022 |
| The senolytic drug JQ1 removes senescent cells via ferroptosis S Go, M Kang, SP Kwon, M Jung, OH Jeon, BS Kim Tissue Engineering and Regenerative Medicine 18 (5), 841-850, 2021 | 27 | 2021 |
| Tolerogenic nanoparticles induce type II collagen–specific regulatory T cells and ameliorate osteoarthritis HS Sohn, JW Choi, JY Jhun, SP Kwon, M Jung, S Yong, HS Na, JH Kim, ... Science advances 8 (47), eabo5284, 2022 | 22 | 2022 |
| A Therapeutic Nanovaccine that Generates Anti‐Amyloid Antibodies and Amyloid‐specific Regulatory T Cells for Alzheimer's Disease M Jung, S Lee, S Park, J Hong, C Kim, I Cho, HS Sohn, K Kim, IW Park, ... Advanced Materials 35 (3), 2207719, 2023 | 19 | 2023 |
| Senescent cancer cell-derived nanovesicle as a personalized therapeutic cancer vaccine J Hong, M Jung, C Kim, M Kang, S Go, HS Sohn, S Moon, S Kwon, ... Experimental & Molecular Medicine 55, 541-554, 2023 | 9 | 2023 |
| A senolytic-eluting coronary stent for the prevention of in-stent restenosis C Kim, SG Lee, S Lim, M Jung, SP Kwon, J Hong, M Kang, HS Sohn, S Go, ... ACS Biomaterials Science & Engineering 8 (5), 1921-1929, 2022 | 8 | 2022 |
| A Personalized Cancer Nanovaccine that Enhances T-Cell Responses and Efficacy through Dual Interactions with Dendritic Cells and T Cells S Go*, M Jung*, S Lee*, S Moon, J Hong, C Kim, Y Chung, BS Kim Advanced Materials, 2303979, 2023 | 7 | 2023 |
| Iron Oxide Nanoparticle-Incorporated Mesenchymal Stem Cells for Alzheimer’s Disease Treatment M Jung, H Kim, JW Hwang, Y Choi, M Kang, C Kim, J Hong, NK Lee, ... Nano Letters 23 (2), 476-490, 2023 | 7 | 2023 |
| Multilayered cell sheets of cardiac reprogrammed cells for the evaluation of drug cytotoxicity SP Kwon, SY Song, J Yoo, HY Kim, JR Lee, M Kang, HS Sohn, S Go, ... Tissue Engineering and Regenerative Medicine 18 (5), 807-818, 2021 | 5 | 2021 |
| 3D hierarchical scaffolds enabled by a post-patternable, reconfigurable, and biocompatible 2D vitrimer film for tissue engineering applications NK Kim, EJ Cha, M Jung, J Kim, GJ Jeong, YS Kim, WJ Choi, BS Kim, ... Journal of Materials Chemistry B 7 (21), 3341-3345, 2019 | 4 | 2019 |
| A Personalized Cancer Vaccine that Induces Synergistic Innate and Adaptive Immune Responses DS Kuen, J Hong, S Lee, CH Koh, M Kwak, BS Kim, M Jung, YJ Kim, ... Advanced Materials 35 (36), 2303080, 2023 | 2 | 2023 |
| The development of therapeutic nanovaccine that elicits anti‐Aβ antibodies and Aβ‐specific regulatory T cells for the treatment of Alzheimer’s disease. S Lee, M Jung, BS Kim, YS Kim Alzheimer's & Dementia 19, e076411, 2023 | | 2023 |
| The senolytic drug JQ1 removes senescent cells via ferroptosis SH Go, M Kang, SP Kwon, M Jung, OH Jeon, BS Kim TISSUE ENGINEERING PART A 28, 538-538, 2022 | | 2022 |
| Type II collagen-specific regulatory T cell-inducing nanoparticle for osteoarthritis HS Sohn, JW Choi, JY Jhun, SP Kwon, M Jung, S Yong, HS Na, BS Kim TISSUE ENGINEERING PART A 28, 109-109, 2022 | | 2022 |
Byung-Soo KimSeoul National University在 snu.ac.kr 的电子邮件经过验证
